@inproceedings{inproceedings, title  = {{Clinically meaningful responses achieved with tralokinumab in adults with moderate-to-severe atopic dermatitis who did not meet IGA 0/1 at initial 16-week treatment}},

 url = {{}},

 year = {{2022}},

 month = {{1}},

 author = {{Simpson E and Blauvelt A and Silverberg JI and Cork M and Katoh N and Mark T and Schneider S and Wollenberg A}},

 volume = {{142}},

 journal = {{JOURNAL OF INVESTIGATIVE DERMATOLOGY}},

 issue = {{8}},

 pages = {{B17-B17}},

 note = {{Accessed on 2024/12/22}}}